Brokerages predict that Kodiak Sciences Inc. (NASDAQ:EVER) will post sales of $85.01 million for the current quarter, Zacks reports. Four analysts have provided estimates for Kodiak Sciences’ earnings, with the highest sales estimate coming in at $85.43 million and the lowest estimate coming in at $84.60 million. Kodiak Sciences posted sales of $67.11 million during the same quarter last year, which suggests a positive year over year growth rate of 26.7%. The business is scheduled to issue its next quarterly earnings results on Monday, November 2nd.
According to Zacks, analysts expect that Kodiak Sciences will report full-year sales of $334.10 million for the current year, with estimates ranging from $333.40 million to $335.70 million. For the next year, analysts forecast that the firm will post sales of $416.40 million, with estimates ranging from $404.24 million to $433.90 million. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for Kodiak Sciences.
Kodiak Sciences (NASDAQ:EVER) last announced its earnings results on Tuesday, August 4th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.05). Kodiak Sciences had a negative net margin of 1.67% and a negative return on equity of 9.24%. The firm had revenue of $78.30 million for the quarter, compared to analyst estimates of $79.06 million.
Kodiak Sciences Company Profile
EverQuote, Inc operates an online marketplace for insurance shopping in the United States. Its online marketplace offers consumers shopping for auto, home and renters, life, health, and commercial insurance. The company serves carriers, agents, and indirect distributors and aggregators. The company was formerly known as AdHarmonics, Inc, and changed its name to EverQuote, Inc in November 2014.
Featured Story: What is the role of the G-20?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Kodiak Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kodiak Sciences and related companies with MarketBeat.com's FREE daily email newsletter.